Reckitt to pay $1.4 billion to end opioid addiction treatment probes
Share:
(Reuters) - Reckitt Benckiser has agreed to pay up to $1.4 billion (£1.1 billion) to end U.S. federal investigations into the marketing of an opioid addiction treatment by its former business Indivior, lifting a cloud that has been hanging over the British company for years.While the settlement is significantly higher than the $400 million that the consumer goods group had set aside to cover the cost of the investigations, analysts said it could allow its new chief executive to focus on a..